Literature DB >> 1697688

Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha.

D B Dubravec1, D R Spriggs, J A Mannick, M L Rodrick.   

Abstract

Circulating peripheral blood polymorphonuclear neutrophils (PMNs) have long been considered terminally differentiated cells that do not synthesize or secrete protein. However, work of others and ourselves has shown that PMNs can secrete the cytokine interleukin 1. In the present study we investigated whether circulating PMNs are capable of synthesizing and secreting another cytokine, tumor necrosis factor alpha (TNF-alpha). Highly purified (greater than 99% granulocytes) PMNs were isolated from normal human volunteer blood and cultured with or without bacterial lipopolysaccharide (LPS) for up to 24 hr. Cell culture supernatants were collected and tested for TNF-alpha, and total RNA was isolated from cells at various times after stimulation and assessed for TNF-alpha mRNA by Northern blot techniques. The results showed that message for TNF-alpha was produced after 60 min of in vitro stimulation with LPS and was maximal at about 4 hr. TNF-alpha was secreted into the supernatant of unstimulated PMNs from two different donors during 24 hr of culture (35-50 pg/ml), but significantly more (160-190 pg/ml) was secreted by PMNs when stimulated with LPS. PMNs from six other normal volunteers showed significant LPS-stimulated secretion of TNF at 60-180 min of culture. The secreted product also had biological activity against the TNF-sensitive L-M cell line, confirming that PMNs can make and secrete immunologically and biologically active TNF. Since it is also possible for monocytes to synthesize and secrete TNF, the amount of TNF secreted by a monocyte population equal to 20% of the PMNs cultured was measured. The results showed that monocytes at a concentration 20 times that potentially contaminating the PMN populations cultured could not produce as much TNF (unstimulated, 26-65 pg/ml; stimulated, 32-87 pg/ml). The PMN must now be considered a cell capable of altering the acute inflammatory response and modulating the immune response through the synthesis and release of cytokines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697688      PMCID: PMC54616          DOI: 10.1073/pnas.87.17.6758

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

Review 1.  Assays for tumour necrosis factor and related cytokines.

Authors:  A Meager; H Leung; J Woolley
Journal:  J Immunol Methods       Date:  1989-01-06       Impact factor: 2.303

2.  Interleukin 1 production by human polymorphonuclear neutrophils.

Authors:  K Tiku; M L Tiku; J L Skosey
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

3.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

4.  Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

Authors:  D R Bertolini; G E Nedwin; T S Bringman; D D Smith; G R Mundy
Journal:  Nature       Date:  1986 Feb 6-12       Impact factor: 49.962

5.  Expression of the c-fms proto-oncogene during human monocytic differentiation.

Authors:  E Sariban; T Mitchell; D Kufe
Journal:  Nature       Date:  1985 Jul 4-10       Impact factor: 49.962

6.  Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2.

Authors:  S Chouaib; J Bertoglio; J Y Blay; C Marchiol-Fournigault; D Fradelizi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

7.  Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor.

Authors:  J A Elias; K Gustilo; W Baeder; B Freundlich
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

8.  Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption.

Authors:  P Stashenko; F E Dewhirst; W J Peros; R L Kent; J M Ago
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

9.  Selective synthesis of mRNA and proteins by human peripheral blood neutrophils.

Authors:  R M Jack; D T Fearon
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

10.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

Authors:  J M Dayer; B Beutler; A Cerami
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  75 in total

Review 1.  Factors influencing airway inflammation in chronic obstructive pulmonary disease.

Authors:  A Hill; S Gompertz; R Stockley
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

2.  Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology.

Authors:  S K Bliss; L C Gavrilescu; A Alcaraz; E Y Denkers
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-alpha, IL-1 beta IL-10 by human leucocytes.

Authors:  A M van Furth; E M Verhard-Seijmonsbergen; R van Furth; J A Langermans
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

4.  Macrophage inflammatory protein 1 alpha expression by synovial fluid neutrophils in rheumatoid arthritis.

Authors:  Y Hatano; T Kasama; H Iwabuchi; R Hanaoka; H T Takeuchi; L Jing; Y Mori; K Kobayashi; M Negishi; H Ide; M Adachi
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

5.  Intratracheal administration of endotoxin and cytokines: VIII. LPS induces E-selectin expression; anti-E-selectin and soluble E-selectin inhibit acute inflammation.

Authors:  T R Ulich; S C Howard; D G Remick; E S Yi; T Collins; K Guo; S Yin; J L Keene; J J Schmuke; C N Steininger
Journal:  Inflammation       Date:  1994-08       Impact factor: 4.092

6.  Effects of anticoagulants and temperature on expression of activation markers CD11b and HLA-DR on human leukocytes.

Authors:  S Shalekoff; L Page-Shipp; C T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

7.  Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein.

Authors:  F R Kohn; A H Kung
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome.

Authors:  C E McCall; L M Grosso-Wilmoth; K LaRue; R N Guzman; S L Cousart
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

9.  Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea.

Authors:  S Nicholls; S Stephens; C P Braegger; J A Walker-Smith; T T MacDonald
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

10.  African swine fever virus infection induces tumor necrosis factor alpha production: implications in pathogenesis.

Authors:  M Gómez del Moral; E Ortuño; P Fernández-Zapatero; F Alonso; C Alonso; A Ezquerra; J Domínguez
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.